Literature DB >> 11982602

Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.

D S S Rodrigues1, E A S Medeiros, L Y Weckx, W Bonnez, R Salomão, E G Kallas.   

Abstract

The cellular immune response probably plays a pivotal role in determining the clinical outcome after exposure to Mycobacterium tuberculosis. We used multi-parameter flow-cytometry to evaluate the distribution of T-lymphocyte subsets during infection and disease caused by M. tuberculosis. Samples were obtained from 71 volunteers to identify the T CD4+ and CD8+ lymphocyte numbers, and the activation plus memory/naïve phenotypes, as defined by CD38, HLA-DR, CD45RA and CD27 markers. Subjects were divided into 18 healthy volunteers without detectable reaction to purified protein derivative (PPD-), 18 health care workers with a recent conversion to PPD, 20 patients with active pulmonary tuberculosis (TBC) and 15 patients with treated TBC at 6 months of therapy. By multiple-comparison analyses, the T CD4+ lymphocyte number of the TBC group was lower than the PPD- group (P < 0.05). This difference was apparently lost after treatment. The higher and the lower number of naïve T CD4+ cells was observed in the PPD- and TBC group, respectively. CD8+ T lymphocytes were also statistically different among the four groups (P = 0.0002), lower in the TBC group (P < 0.05). CD8+ T lymphocyte activation was evaluated by the CD38 and HLA-DR surface expression. The percentage distribution of these markers was statistically different between the four groups (P = 0.0055). TBC patients had a higher percentage of CD38+ cells and mean fluorescence index, suggesting an overall increase of cell activation. These results suggest that peripheral T lymphocytes reflect cellular activation during TBC, along with possible redistribution of naïve, memory/effector and late differentiated memory/effector phenotypes in the peripheral blood after infection and disease caused by M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982602      PMCID: PMC1906372          DOI: 10.1046/j.1365-2249.2002.01809.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Peripheral blood T lymphocyte subpopulations in patients with tuberculosis and the effect of chemotherapy.

Authors:  M Singhal; J N Banavalikar; S Sharma; K Saha
Journal:  Tubercle       Date:  1989-09

2.  Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alphabetaTCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra.

Authors:  K Tsukaguchi; B de Lange; W H Boom
Journal:  Cell Immunol       Date:  1999-05-25       Impact factor: 4.868

3.  Characteristics and specificity of acquired immunologic memory to Mycobacterium tuberculosis infection.

Authors:  I M Orme
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

4.  Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives.

Authors:  M Peakman; T Warnock; A Vats; G L McNab; J Underhill; P T Donaldson; D Vergani
Journal:  Diabetologia       Date:  1994-02       Impact factor: 10.122

5.  Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen.

Authors:  P Mombaerts; J Arnoldi; F Russ; S Tonegawa; S H Kaufmann
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

6.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; B Koller; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

7.  Normalization of CD4+ T-lymphocyte depletion in patients without HIV infection treated for tuberculosis.

Authors:  G S Turett; E E Telzak
Journal:  Chest       Date:  1994-05       Impact factor: 9.410

8.  Idiopathic CD4+ T-lymphocyte depletion in a west African population.

Authors:  G Djomand; L Diaby; J M N'Gbichi; D Coulibaly; A Kadio; A Yapi; J M Kanga; E Boateng; K Diallo; L Kestens
Journal:  AIDS       Date:  1994-06       Impact factor: 4.177

9.  Generation of cytolytic T cells in individuals infected by Mycobacterium tuberculosis and vaccinated with BCG.

Authors:  A D Pithie; M Rahelu; D S Kumararatne; P Drysdale; J S Gaston; P B Iles; J A Innes; C J Ellis
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139

10.  Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery.

Authors:  G M Ainslie; J A Solomon; E D Bateman
Journal:  Thorax       Date:  1992-07       Impact factor: 9.139

View more
  26 in total

1.  Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders.

Authors:  H Veenstra; R Baumann; N M Carroll; P T Lukey; M Kidd; N Beyers; C T Bolliger; P D van Helden; G Walzl
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

2.  Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.

Authors:  Toidi Adekambi; Chris C Ibegbu; Stephanie Cagle; Ameeta S Kalokhe; Yun F Wang; Yijuan Hu; Cheryl L Day; Susan M Ray; Jyothi Rengarajan
Journal:  J Clin Invest       Date:  2015-03-30       Impact factor: 14.808

3.  Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis.

Authors:  Alexandre S de Almeida; Christina T Fiske; Timothy R Sterling; Spyros A Kalams
Journal:  Clin Vaccine Immunol       Date:  2011-10-28

4.  Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis.

Authors:  R M de Castro Cunha; E G Kallas; D S Rodrigues; M Nascimento Burattini; R Salomao
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

5.  Polyfunctional Mycobacterium tuberculosis-specific effector memory CD4+ T cells at sites of pleural TB.

Authors:  L El Fenniri; Z Toossi; H Aung; G El Iraki; J Bourkkadi; J Benamor; A Laskri; N Berrada; A Benjouad; H Mayanja-Kizza; M R Betts; R El Aouad; D H Canaday
Journal:  Tuberculosis (Edinb)       Date:  2011-04-02       Impact factor: 3.131

6.  Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3.

Authors:  Christina L Lancioni; C Scott Mahan; Denise F Johnson; Maria Walusimbi; Keith A Chervenak; Sophie Nalukwago; Edwin Charlebois; Diane Havlir; Harriet Mayanja-Kizza; Christopher C Whalen; W Henry Boom
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

7.  In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.

Authors:  Madeline Slater; Minh-Chi Tran; Lauren Platt; Lien T Luu; Ha T Phan; Phuong T Pham; Tam B Do; Hanh T Nguyen; Rajiv L Gaur; Julie Parsonnet; Adithya Cattamanchi; Robert Luo; Payam Nahid; Niaz Banaei
Journal:  Diagn Microbiol Infect Dis       Date:  2015-05-19       Impact factor: 2.803

Review 8.  Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection.

Authors:  Esaki M Shankar; Vijayakumar Velu; Adeeba Kamarulzaman; Marie Larsson
Journal:  World J Virol       Date:  2015-02-12

9.  Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.

Authors:  Karina I Carvalho; Solange Maeda; Luciana Marti; Jane Yamashita; Patrick A J Haslett; Esper G Kallas
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

10.  Intracellular expression of interleukin-4 and interferon-gamma by a Mycobacterium tuberculosis antigen-stimulated CD4+ CD57+ T-cell subpopulation with memory phenotype in tuberculosis patients.

Authors:  Maria C Jiménez-Martínez; Marisela Linares; Renata Báez; Luis F Montaño; Salvador Martínez-Cairo; Patricia Gorocica; Raúl Chávez; Edgar Zenteno; Ricardo Lascurain
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.